Form 483

DIAGAST Form 483, 2024-04-19

FDA issued a Form 483 to DIAGAST on 2024-04-19 with 6 public-safe observations.

483· Form 483 issuedBiologics6 observations

DIAGAST · Loos, France · Issued April 19, 2024

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Apr 2024
21 CFR 600.14(a)(1)

Who must report - manufacturer

Cited by Richard T Riggie, Creighton T Tuzon, Elias N Paz Alonzo

19 Apr 2024
21 CFR 803.17(b)(1)

Info evaluated to determine if event was reportable

Cited by Richard T Riggie, Creighton T Tuzon, Elias N Paz Alonzo

19 Apr 2024
21 CFR 803.50(a)(2)

Individual Report of Malfunction

Cited by Richard T Riggie, Creighton T Tuzon, Elias N Paz Alonzo

19 Apr 2024
21 CFR 820.150

Lack of or inadequate procedures for storage.

Cited by Richard T Riggie, Creighton T Tuzon, Elias N Paz Alonzo

19 Apr 2024
21 CFR 820.30(g)

Design Validation - Risk analysis not performed/inadequate

Cited by Richard T Riggie, Creighton T Tuzon, Elias N Paz Alonzo

Inspected site

DDIAGASTLoos, France

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 600.14(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 803.17(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 803.50(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.150Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.80(c)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere